SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001897612-23-000742
Filing Date
2023-02-14
Accepted
2023-02-14 12:40:55
Documents
1
Confirming Copy
 

Document Format Files

Seq Description Document Type Size
1 apls13gdec22.txt SC 13G 5392
  Complete submission text file 0001897612-23-000742.txt   6827
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Subject) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90187
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 EAST PRATT STREET BALTIMORE MD 21202
Business Address 100 EAST PRATT STREET BALTIMORE MD 21202 000-000-0000
T. Rowe Price Investment Management, Inc. (Filed by) CIK: 0001897612 (see all company filings)

IRS No.: 854328500 | State of Incorp.: MD | Fiscal Year End: 1231
Type: SC 13G